Latest market price
46.98
+0.14+0.30%
TA
Loading chart...
Snapshot
| Index | — | P/E | 16.78 | EPS (ttm) | 2.80 | Insider Own | 1.40% | Shs Outstand | 303.01M | Perf Week | 1.62% |
| Market Cap | 14.24B | Forward P/E | 23.25 | EPS next Y | 2.02 | Insider Trans | 0.00% | Shs Float | 302.04M | Perf Month | 3.87% |
| Enterprise Value | 18.22B | PEG | — | EPS next Q | 0.47 | Short Float | 4.98% | Perf Quarter | -4.14% | ||
| Income | 859.00M | P/S | 11.01 | EPS this Y | 37.35% | Short Ratio | 7.77 | Perf Half Y | 0.00% | ||
| Sales | 1.29B | P/B | 2.52 | EPS next Y | -23.84% | ROA | 8.55% | Short Interest | 15.05M | Perf YTD | 5.95% |
| Book/sh | 18.62 | P/C | — | EPS next 5Y | — | ROE | 16.51% | 52W High | 52.39 -10.33% | Perf Year | 18.85% |
| Cash/sh | 0.13 | P/FCF | 15.76 | EPS past 3/5Y | 2.53% 23.33% | ROIC | 34.60% | 52W Low | 39.38 19.30% | Perf 3Y | 39.90% |
| Dividend Est. | 2.72 (5.79%) | EV/EBITDA | 12.58 | Sales past 3/5Y | 10.91% 6.08% | Gross Margin | 71.96% | Volatility | 1.95% 2.08% | Perf 5Y | 53.73% |
| Dividend TTM | 2.69 (5.73%) | EV/Sales | 14.09 | EPS Y/Y TTM | 72.84% | Oper. Margin | 62.39% | ATR (14) | 1.00 | Perf 10Y | 41.72% |
| Dividend Ex-Date | Nov 05, 2026 | Quick Ratio | 0.91 | Sales Y/Y TTM | 15.96% | Profit Margin | 66.43% | RSI (14) | 56.80 | Recom | 2.83 |
| Dividend Gr. 3/5Y | 0.00% 0.00% | Current Ratio | 0.91 | EPS Q/Q | 158.70% | SMA20 | 3.35% | Beta | 0.55 | Target Price | 49.56 |
| Payout | 92.63% | Debt/Eq | 0.71 | Sales Q/Q | 18.73% | SMA50 | 1.80% | Rel Volume | 1.23 | Prev Close | 46.84 |
| Employees | 69 | LT Debt/Eq | 0.71 | Earnings | Nov 03 | SMA200 | 0.79% | Avg Volume | 1.90M | Price | 46.98 |
| IPO Date | Aug 07, 1992 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 133.98% -1.59% | Net Debt/EBITDA | 2.75 | Volume | 2,333,037 | Change | 0.30% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-22-26 | Upgrade | Citizens | Market Perform → Market Outperform | |
| Oct-19-26 | Reiterated | Wells Fargo | Equal Weight | $48 → $46 |
| Oct-13-26 | Reiterated | Barclays | Underweight | $50 → $48 |
| Oct-06-26 | Reiterated | Raymond James | Outperform | $55 → $53 |
| Aug-31-26 | Reiterated | Barclays | Underweight | $51 → $50 |
| Aug-31-26 | Reiterated | Mizuho | Neutral | $35 → $46 |
| Jul-31-26 | Reiterated | Cantor Fitzgerald | Overweight | $52 → $56 |
| Jul-07-26 | Downgrade | Barclays | Equal Weight → Underweight | $29 → $51 |
| Jun-18-26 | Reiterated | UBS | Buy | $50 → $47 |
| Jun-16-26 | Resumed | Raymond James | Outperform | $50 |
Latest News· Times ET
Oct-29-26
Oct-29-2602:48PM
Oct-26-26
11:45AM
Oct-24-26
Oct-24-2612:00PM
Oct-23-26
Oct-23-2611:45AM
Oct-22-26
Oct-20-26
Oct-16-26
Oct-15-26
Oct-14-26
08:45AM
Oct-12-26
Oct-07-26
07:15AM
Company
Omega Healthcare Investors, Inc. functions as a Real Estate Investment Trust (REIT) primarily focused on the long-term healthcare sector. The company strategically invests in properties providing skilled nursing and assisted living services. A diverse array of healthcare operators manage these assets, predominantly utilizing a triple-net lease framework. Its portfolio is geographically distributed across all regions of the United States and also includes holdings in the United Kingdom.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,293 | 1,198 | 1,051 | 950 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 363 | 665 | 15 | 15 | — | — | — | — | — | |
| Gross Profit | 930 | 533 | 1,037 | 935 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 64 | 0 | 88 | 82 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 60 | -216 | 289 | 364 | — | — | — | — | — | |
| Operating Income | 806 | 749 | 660 | 489 | — | — | — | — | — | |
| Interest Expense | 208 | 221 | 222 | 236 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 313 | 95 | -9 | 2 | — | — | — | — | — | |
| Net Income Before Taxes | 911 | 624 | 429 | 255 | — | — | — | — | — | |
| Income Taxes | 16 | 15 | 11 | 6 | — | — | — | — | — | |
| Consolidated Net Income | 859 | 590 | 406 | 242 | — | — | — | — | — | |
| Net Income From Continuing Operations | 896 | 609 | 418 | 249 | — | — | — | — | — | |
| Net Income | 859 | 590 | 406 | 242 | — | — | — | — | — | |
| EPS (Recurring) | 2.89 | 2.02 | 1.57 | 1.01 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 2.89 | 2.02 | 1.57 | 1.01 | — | — | — | — | — | |
| EPS (Diluted) | 2.80 | 1.94 | 1.55 | 1.00 | — | — | — | — | — | |
| EBITDA | 1,449 | 1,170 | 947 | 811 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 16.78 | 22.86 | 24.42 | 30.66 | — | — | — | — | — | |
| Price To Sales Ratio | 10.86 | 10.96 | 9.29 | 7.75 | — | — | — | — | — | |
| Gross Margin | 71.93 | 44.49 | 98.67 | 98.42 | — | — | — | — | — | |
| Operating Margin | 62.34 | 62.52 | 62.80 | 51.47 | — | — | — | — | — | |
| Net Margin | 66.43 | 49.25 | 38.63 | 25.47 | — | — | — | — | — | |
| Shares Outstanding | 299 | 296 | 258 | 240 | — | — | — | — | — | |
| Market Capitalization | 14,047 | 13,125 | 9,765 | 7,358 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Golem Lucas M. | CHIEF ACCOUNTING OFFICER | Sep 30 '26 | Option Exercise | 0.00 | 3,826 | 0 | 35,564 | Oct 01 |
| Gupta Vikas | Chief Investment Officer | Sep 30 '26 | Option Exercise | 0.00 | 20,482 | 0 | 266,952 | Sep 30 |
| PICKETT C TAYLOR | CHIEF EXECUTIVE OFFICER | Sep 30 '26 | Option Exercise | 0.00 | 95,402 | 0 | 1,415,808 | Sep 30 |
| Gourmand Matthew Paul | President | Sep 30 '26 | Option Exercise | 0.00 | 20,482 | 0 | 252,840 | Sep 30 |
| Ballew Neal | CHIEF FINANCIAL OFFICER | Sep 30 '26 | Option Exercise | 0.00 | 20,482 | 0 | 189,286 | Sep 30 |
| Makode Gail D | CHIEF LEGAL OFFICER | Sep 30 '26 | Option Exercise | 0.00 | 20,482 | 0 | 265,472 | Sep 30 |
| Makode Gail D | CHIEF LEGAL OFFICER | Jun 30 '26 | Option Exercise | 0.00 | 20,482 | 0 | 244,990 | Jul 01 |
| STEPHENSON ROBERT O | CHIEF FINANCIAL OFFICER | Jun 30 '26 | Option Exercise | 0.00 | 39,649 | 0 | 758,743 | Jul 01 |
| PICKETT C TAYLOR | CHIEF EXECUTIVE OFFICER | Jun 30 '26 | Option Exercise | 0.00 | 95,403 | 0 | 1,320,406 | Jul 01 |
| Gupta Vikas | Chief Investment Officer | Jun 30 '26 | Option Exercise | 0.00 | 20,482 | 0 | 246,470 | Jul 01 |
| Gourmand Matthew Paul | President | Jun 30 '26 | Option Exercise | 0.00 | 20,482 | 0 | 232,358 | Jul 01 |
| Ballew Neal | CHIEF ACCOUNTING OFFICER | Jun 30 '26 | Option Exercise | 0.00 | 20,482 | 0 | 168,804 | Jul 01 |
| PLAVIN STEPHEN D | Director | Jun 05 '26 | Option Exercise | 0.00 | 4,424 | 0 | 23,215 | Jun 09 |
| HILL BARBARA B | Director | Jun 05 '26 | Option Exercise | 0.00 | 7,079 | 0 | 49,073 | Jun 09 |
| CALLEN CRAIG R | Director | Jun 06 '25 | Option Exercise | 0.00 | 23,407 | 0 | 74,310 | Jun 09 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.